Reflecting the geographic and demographic expanse of our ADRC, principle sites of the Clinical Core are at USC in Los Angeles County and UCI in Orange County. The Clinical Core will continue to facilitate ADRC goals related to Alzheimer's disease (AD), aging, and dementia through the recruitment of demented and nondemented elderly control subjects; medical, neuropsychological, and laboratory evaluation; and clinical data analysis. The Clinical Core is essential to the Neuropathology Core at USC and UCI to make postmortem tissues available for basic neurobiological studies.
Specific aims are (1) to provide well- characterized, longitudinally-assessed AD and nondemented """"""""normal control"""""""" populations for clinical and autopsy research needs of the ADRC; (2) to provide information as a Core resources on clinical findings that are relevant to patterns of cognitive impairment, patterns of neurological deficits, ethnicity, and gender; (3) to catalyze new clinical research projects and to facilitate links between clinical and basic researchers; (4) to provide a setting for training and support services in Los Angeles and Orange Counties; (5) and to support needs of proposed ADRC-sponsored grants. In years 11-15, the Clinical Core at USC will maintain its autopsy requirement for AD and control subjects, will forge closer parallel efforts with the Spanish-Speaking AD Research Program in the Satellite Subcore, and beginning in Year 12 will establish a Parkinsonism Dementia Research Program as a core resource for ADRC participating investigators. The Clinical Core at UCI will develop clinical phenotypes based on functional abilities (egs, selected preserved recognition, preserved insight). Minority recruitment will remain a major focus at USC and UCI.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005142-13
Application #
5204491
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
13
Fiscal Year
1996
Total Cost
Indirect Cost
Gallagher, Damien; Kiss, Alex; Lanctot, Krista L et al. (2018) Toward Prevention of Mild Cognitive Impairment in Older Adults With Depression: An Observational Study of Potentially Modifiable Risk Factors. J Clin Psychiatry 80:
Lin, Ming; Gong, Pinghua; Yang, Tao et al. (2018) Big Data Analytical Approaches to the NACC Dataset: Aiding Preclinical Trial Enrichment. Alzheimer Dis Assoc Disord 32:18-27
Weissberger, Gali H; Nation, Daniel A; Nguyen, Caroline P et al. (2018) Meta-analysis of cognitive ability differences by apolipoprotein e genotype in young humans. Neurosci Biobehav Rev 94:49-58
Kirson, Noam Y; Scott Andrews, J; Desai, Urvi et al. (2018) Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease. J Alzheimers Dis 61:295-307
Barnes, Josephine; Bartlett, Jonathan W; Wolk, David A et al. (2018) Disease Course Varies According to Age and Symptom Length in Alzheimer's Disease. J Alzheimers Dis 64:631-642
Wang, Junyan; Aydogan, Dogu Baran; Varma, Rohit et al. (2018) Modeling topographic regularity in structural brain connectivity with application to tractogram filtering. Neuroimage 183:87-98
Joe, Elizabeth; Medina, Luis D; Ringman, John M et al. (2018) 1H MRS spectroscopy in preclinical autosomal dominant Alzheimer disease. Brain Imaging Behav :
Aydogan, Dogu Baran; Shi, Yonggang (2018) Tracking and validation techniques for topographically organized tractography. Neuroimage 181:64-84
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Weintraub, Sandra; Besser, Lilah; Dodge, Hiroko H et al. (2018) Version 3 of the Alzheimer Disease Centers' Neuropsychological Test Battery in the Uniform Data Set (UDS). Alzheimer Dis Assoc Disord 32:10-17

Showing the most recent 10 out of 590 publications